Ocular Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Ocular Cancer Drug Development Pipeline Review, 2018

  • Report
  • 63 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • Report
  • 171 Pages
From
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence - Product Thumbnail Image

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

  • Report
  • 170 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H1 2018 - Product Thumbnail Image

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H1 2018

  • Report
  • 88 Pages
From
Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022

  • Report
  • 157 Pages
From
Breast Cancer Diagnostic and Drug Technologies: Global Markets - Product Thumbnail Image

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • Report
  • 154 Pages
From
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market - Product Thumbnail Image

Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

  • Report
  • 176 Pages
From
Histone Deacetylase 3 (SMAP45 or EC 3.5.1.98) - Pipeline Review, H1 2016 - Product Thumbnail Image

Histone Deacetylase 3 (SMAP45 or EC 3.5.1.98) - Pipeline Review, H1 2016

  • Report
  • 81 Pages
From
Fallopian Tube Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Review, H1 2018

  • Report
  • 950 Pages
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Report
  • 2412 Pages
From
Fallopian Tube Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Review, H2 2017

  • Report
  • 875 Pages
From
Metastatic Breast Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Review, H2 2016

  • Report
  • 1096 Pages
From
Uveal Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Uveal Melanoma - Pipeline Review, H1 2018

  • Report
  • 185 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Report
  • 2011 Pages
From
Uveal Melanoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Uveal Melanoma - Pipeline Review, H2 2017

  • Report
  • 155 Pages
From
Renal Cell Carcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Review, H2 2016

  • Report
  • 793 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • Report
  • 3034 Pages
From
Metastatic Melanoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H2 2016

  • Report
  • 648 Pages
From
Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 - Product Thumbnail Image

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • Report
  • 567 Pages
From
Loading Indicator
adroll